Placental transfer of third-generation antiepileptic drugs: in vivo lacosamide case study and in vitro investigation of transporter inhibition by lacosamide and perampanel
Abstract Background Antiepileptic drugs must be continually used to control seizures in pregnant people with epilepsy. Lacosamide (LCM) and perampanel (PER) are third-generation antiepileptic drugs that were introduced to clinical practice in 2008 and 2012, respectively. LCM and PER are increasingly...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2026-01-01
|
| Серии: | Journal of Pharmaceutical Health Care and Sciences |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s40780-025-00537-z |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|